G

GREAT POINT PARTNERS LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for GREAT POINT PARTNERS LLC with $226.8M in long positions as of Q3 2025, 85% allocated to Healthcare, and 66% concentrated in top 10 positions.

Portfolio Value
$226.8M
Top 10 Concentration
66%
Top Sector
Healthcare (85%)
US Exposure
93%
Market Cap Focus
Small Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 85.30%Healthcare
Healthcare
85.30%

Industry Breakdown

1 industry across all sectors

Biotechnology: 85.34%Biotechnology
Biotechnology
Healthcare
85.34%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 2.31%Mid Cap ($2B - $10B): 24.94%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 42.56%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 18.86%Micro Cap ($50M - $300M)Nano Cap (< $50M): 3.12%N/A (ETF or Unknown): 8.21%N/A (ETF or Unknown)
Large Cap ($10B - $200B)
2.31%
Mid Cap ($2B - $10B)
24.94%
Small Cap ($300M - $2B)
42.56%
Micro Cap ($50M - $300M)
18.86%
Nano Cap (< $50M)
3.12%
N/A (ETF or Unknown)
8.21%

Portfolio Concentration

Top 10 Holdings %
65.57%
Top 20 Holdings %
90.9%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
93.08%
International
6.92%
Countries
4
Largest Int'l Market
Canada - 3.54%
United States of America
93.08% ($211.1M)
24 holdings
Canada
3.54% ($8.0M)
1 holdings
Netherlands
1.71% ($3.9M)
1 holdings
France
1.67% ($3.8M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
3.3 quarters
Avg. Top 20
3 quarters
Avg. All Positions
2.9 quarters
Median Holding Period
2 quarters
Persistence Rate
29.63%
Persistent Holdings Weight
25.34%
Persistent Positions
8
Longest Held
Pliant Therapeutics, Inc. Common Stock logo
Pliant Therapeutics, Inc. Common StockPLRX - 13 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
2.74%
Avg. Position Weight
3.70%
Largest Position
Amylyx Pharmaceuticals, Inc. Common Stock logo
Amylyx Pharmaceuticals, Inc. Common StockAMLX - 10.19%
Largest Ownership Stake
Zura Bio Limited Class A Ordinary Shares logo
Zura Bio Limited Class A Ordinary SharesZURA - 5.87%
Avg. Ownership Stake
1.50%
Ownership Stake >5%
2
Ownership Stake >1%
10

Historical (Since Q3 2013)

Avg. New Position
3.53%
Avg. Ownership Stake
2.09%
Largest Position
Cassava Sciences, Inc. logo
Cassava Sciences, Inc.SAVA - 43.34% (Q4 2013)
Largest Ownership Stake
OPTN
OptiNose, Inc. Common StockOPTN - 12.14% (Q2 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
38.2%
Value Traded
$86.59M
Positions Added
5
Positions Exited
8

Historical (Since Q3 2013)

Avg. Turnover Ratio
33.0%
Avg. Positions Added
8
Avg. Positions Exited
9
Highest Turnover
107.4%
Q4 2020
Lowest Turnover
11.1%
Q4 2015

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.